Evidence map›Paper›PMID 42360142›Full record

ArticleRadiology. Imaging cancer2026

AI-assisted Radiomic Model for Cervical Cancer Recurrence Prediction: A Multicenter Retrospective Study with Experimental Validation.

Shuqing Chen, Yu Zhang, Dong Chen, Jun Dang, Lei Chen, Wei Yang

Abstract readMulticenter StudyValidation Study
In one paragraph

Article in Radiology. Imaging cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shuqing Chen *Department of Radiology, Funan County People's Hospital, Fuyang, Anhui, PR China.
Yu Zhang *Department of Radiology, The First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, PR China.ORCID 0000-0002-5394-1686
Dong ChenDepartment of Radiology, The First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, PR China.
Jun DangDepartment of Radiology, Funan County People's Hospital, Fuyang, Anhui, PR China.
Lei ChenDepartment of Radiology, Funan County People's Hospital, Fuyang, Anhui, PR China.ORCID 0009-0003-5372-6577
Wei YangDepartment of Interventional Vascular Medicine, Chuzhou Affiliated Hospital of Anhui Medical University, No. 121 Langya West Road, Langya District, Chuzhou, Anhui Province, 239000, PR China.ORCID 0009-0000-6550-6406

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose To evaluate the value of a nomogram model incorporating clinical parameters, hematologic inflammatory biomarkers, and MRI radiomic features in predicting postoperative disease-free survival (DFS) in patients with cervical cancer and to explore the biologic mechanism underlying the radiomic signature. Materials and Methods This multicenter retrospective study enrolled 804 patients with cervical cancer (2016-2023), with a median follow-up of 43.7 months. Three-dimensional radiomic features were extracted from pretreatment MRI tumor and 5-mm peritumoral regions. Five machine learning algorithms were tested to construct the optimal radiomics score (Radscore). Multivariable Cox regression was used to develop the nomogram model, with bioinformatic analysis and in vitro experiments for biologic mechanism validation. Results In the clinical prediction cohort (

Indexed as

Magnetic Resonance ImagingNeoplasm Recurrence, LocalRadiomicsUterine Cervical NeoplasmsArtificial IntelligenceDisease-Free SurvivalFemaleHumansMachine LearningMiddle AgedNomogramsRetrospective StudiesCervical CancerInflammatory MarkersMachine LearningMRIPrognosis and PredictionRadiomicsRecurrence

Identifiers

PMID42360142
PMCPMC13435133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.